triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 600 participants.
Also called NCT07440381
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 600 participants
- Registry
-
NCT07440381
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07440381. Randomized; no masking; primary purpose treatment. Start 2026-09 (anticipated); primary completion 2027-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE
- Acronym
- PERSUADE
- Condition
- Acute Coronary Syndromes
- Condition
- Secondary Prevention
- Condition
- Lipids
- Intervention (Drug)
- Triple oral lipid lowering treatment
- Lead sponsor
- Heart Care Foundation
- Collaborator
- Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Record details
- Record id
cardio:ct-nct07440381- Content hash
41a5548a0f4df68fedfd66ea1b14068a2c9c73ce729058bab433e1a1ea13e989